SOFT TISSUE FOREIGN BODIES

Feb 13, 2017 by in EMERGENCY MEDICINE Comments Off on SOFT TISSUE FOREIGN BODIES

Only a small percentage of wounds contain a foreign body. Most but not all foreign bodies may be discovered with thorough wound examination. PATHOPHYSIOLOGY Retained foreign bodies may lead to…

read more

RHABDOMYOLYSIS

Feb 13, 2017 by in EMERGENCY MEDICINE Comments Off on RHABDOMYOLYSIS

Conditions associated with rhabdomyolysis are listed in Table 53-1. Comatose patients are at risk for rhabdomyolysis due to prolonged immobilization with continual pressure on gravity-dependent parts of the body. TABLE…

read more

ANTICHOLINERGICS

Feb 13, 2017 by in EMERGENCY MEDICINE Comments Off on ANTICHOLINERGICS

Anticholinergic toxicity is encountered because of the common use of phenothiazines, mydriatics, skeletal muscle relaxants, antihistamines (particularly diphenhydramine), antidepressants, antispasmotics, and antiparkinsonian drugs. Jimsonweed is a plant associated with anticholinergic…

read more

HERNIA IN ADULTS AND CHILDREN

Feb 13, 2017 by in EMERGENCY MEDICINE Comments Off on HERNIA IN ADULTS AND CHILDREN

Nearly 10% of the population develops a hernia during their lifetime. Hernias are classified by anatomic location, hernia contents, and the status of those contents (eg, reducible, incarcerated, or strangulated)….

read more

CARDIOGENIC SHOCK

Feb 13, 2017 by in EMERGENCY MEDICINE Comments Off on CARDIOGENIC SHOCK

Cardiogenic shock is the most common cause of in-hospital mortality from acute myocardial infarction (AMI). Approximately 6% to 8% of patients with AMI will develop cardiogenic shock. Cardiogenic shock usually…

read more

HEMOPTYSIS

Feb 13, 2017 by in EMERGENCY MEDICINE Comments Off on HEMOPTYSIS

Hemoptysis is defined somewhat arbitrarily as mild (less than 20 mL of blood loss in 24 hours), moderate, or massive (greater than 600 mL of blood loss in 24 hours)….

read more

OCCLUSIVE ARTERIAL Jv DISEASE

Feb 13, 2017 by in EMERGENCY MEDICINE Comments Off on OCCLUSIVE ARTERIAL Jv DISEASE

The disease prevalence is 4.3% in Americans under age 40 years; prevalence climbs to 15.5% in those >70 years of age. High-risk individuals include those over 70 years of age,…

read more
Get Clinical Tree app for offline access